Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 52

1.

Diagnostic accuracy of 16S rDNA PCR in bacterial pyomyositis: A prospective study.

Gabas T, Podglajen I, Cheminet G, Gagnard JC, Wyplosz B.

J Infect. 2019 Aug 17. pii: S0163-4453(19)30248-8. doi: 10.1016/j.jinf.2019.08.008. [Epub ahead of print] No abstract available.

PMID:
31430482
2.

Persistence of Yellow Fever Immunization-Induced Antibodies in Allogeneic Hematopoietic Stem Cell Transplant Recipients.

Adler M, Lapierre V, Sakr R, Bourhis JH, Gachot B, Castilla-Llorente C, Wyplosz B.

J Infect Dis. 2018 May 5;217(11):1844-1845. doi: 10.1093/infdis/jiy050. No abstract available.

PMID:
29547928
3.

Early and delayed post-pneumonectomy empyemas: Microbiology, management and prognosis.

Stern JB, Fournel L, Wyplosz B, Girard P, Al Nakib M, Gossot D, Seguin-Givelet A.

Clin Respir J. 2018 Apr;12(4):1753-1761. doi: 10.1111/crj.12740. Epub 2017 Dec 12.

PMID:
29114998
4.

Enterocytozoon bieneusi Microsporidiosis in Stem Cell Transplant Recipients Treated with Fumagillin

Bukreyeva I, Angoulvant A, Bendib I, Gagnard JC, Bourhis JH, Dargère S, Bonhomme J, Thellier M, Gachot B, Wyplosz B.

Emerg Infect Dis. 2017 Jun;23(6):1039-1041. doi: 10.3201/eid2306.161825.

5.

Use of ceftolozane/tazobactam as salvage therapy for infections due to extensively drug-resistant Pseudomonas aeruginosa.

Dinh A, Wyplosz B, Kernéis S, Lebeaux D, Bouchand F, Duran C, Béraud G, Lazaro P, Davido B, Hénard S, Canouï E, Ferry T, Wolff M.

Int J Antimicrob Agents. 2017 Jun;49(6):782-783. doi: 10.1016/j.ijantimicag.2017.04.001. Epub 2017 Apr 12. No abstract available.

PMID:
28412272
6.

Prolonged suppressive antibiotic therapy for prosthetic joint infection in the elderly: a national multicentre cohort study.

Prendki V, Ferry T, Sergent P, Oziol E, Forestier E, Fraisse T, Tounes S, Ansart S, Gaillat J, Bayle S, Ruyer O, Borlot F, Le Falher G, Simorre B, Dauchy FA, Greffe S, Bauer T, Bell EN, Martha B, Martinot M, Froidure M, Buisson M, Waldner A, Lemaire X, Bosseray A, Maillet M, Charvet V, Barrelet A, Wyplosz B, Noaillon M, Denes E, Beretti E, Berlioz-Thibal M, Meyssonnier V, Fourniols E, Tliba L, Eden A, Jean M, Arvieux C, Guignery-Kadri K, Ronde-Oustau C, Hansmann Y, Belkacem A, Bouchand F, Gavazzi G, Herrmann F, Stirnemann J, Dinh A.

Eur J Clin Microbiol Infect Dis. 2017 Sep;36(9):1577-1585. doi: 10.1007/s10096-017-2971-2. Epub 2017 Apr 4.

PMID:
28378243
7.

Visualizing viable Mycobacterium tuberculosis in sputum to monitor isolation measures.

Wyplosz B, Mougari F, Al Rawi M, Baillon C, Marigot-Outtandy D, Le Dû D, Jachym M, Hervé V, Raskine L, Cambau E.

J Infect. 2017 Feb;74(2):207-210. doi: 10.1016/j.jinf.2016.11.014. Epub 2016 Dec 7. No abstract available.

PMID:
27939814
8.

[Endobronchial ultrasonography (EBUS) for the internist].

Stern JB, Wyplosz B, Girard P, Validire P, Escaut L, Caliandro R.

Rev Med Interne. 2016 Nov;37(11):759-765. doi: 10.1016/j.revmed.2016.05.021. Epub 2016 Jun 28. Review. French.

PMID:
27363931
9.

Intention to vaccinate against influenza among health care workers caring for immunocompromised patients.

Loulergue P, Kernéis S, Stern JB, Kassis-Chikani N, Derradji O, Escaut L, Launay O, Vittecoq D, Wyplosz B.

Am J Infect Control. 2016 Sep 1;44(9):1080-2. doi: 10.1016/j.ajic.2016.02.030. Epub 2016 Apr 22. No abstract available.

PMID:
27112367
10.

High Rate of Acquisition but Short Duration of Carriage of Multidrug-Resistant Enterobacteriaceae After Travel to the Tropics.

Ruppé E, Armand-Lefèvre L, Estellat C, Consigny PH, El Mniai A, Boussadia Y, Goujon C, Ralaimazava P, Campa P, Girard PM, Wyplosz B, Vittecoq D, Bouchaud O, Le Loup G, Pialoux G, Perrier M, Wieder I, Moussa N, Esposito-Farèse M, Hoffmann I, Coignard B, Lucet JC, Andremont A, Matheron S.

Clin Infect Dis. 2015 Aug 15;61(4):593-600. doi: 10.1093/cid/civ333. Epub 2015 Apr 22.

PMID:
25904368
11.

Delayed-onset hemolytic anemia in patients with travel-associated severe malaria treated with artesunate, France, 2011-2013.

Jauréguiberry S, Thellier M, Ndour PA, Ader F, Roussel C, Sonneville R, Mayaux J, Matheron S, Angoulvant A, Wyplosz B, Rapp C, Pistone T, Lebrun-Vignes B, Kendjo E, Danis M, Houzé S, Bricaire F, Mazier D, Buffet P, Caumes E; French Artesunate Working Group.

Emerg Infect Dis. 2015 May;21(5):804-12. doi: 10.3201/eid2105.141171.

12.

Low immunogenicity of quadrivalent meningococcal vaccines in solid organ transplant recipients.

Wyplosz B, Derradji O, Hong E, François H, Durrbach A, Duclos-Vallée JC, Samuel D, Escaut L, Launay O, Vittecoq D, Taha MK.

Transpl Infect Dis. 2015 Apr;17(2):322-7. doi: 10.1111/tid.12359. Epub 2015 Mar 6.

13.

Survey of French physician practices in treatment and control of transmission of smear-positive tuberculosis.

Méchaï F, Figoni J, Wyplosz B, Aoun O, Bouchaud O, Robert J.

Int J Tuberc Lung Dis. 2015 Feb;19(2):205-9. doi: 10.5588/ijtld.14.0470.

PMID:
25574920
14.

Photo quiz. Dyspnea and fever in an allogeneic stem cell recipient.

Angoulvant A, Stern JB, Wittnebel S, Bourhis JH, Gachot B, Vittecoq D, Wyplosz B.

Clin Infect Dis. 2015 Jan 1;60(1):100, 157-8. doi: 10.1093/cid/ciu839. No abstract available.

PMID:
25504499
15.

Worsening pneumonitis due to a pharmacokinetic drug-drug interaction between everolimus and voriconazole in a renal transplant patient.

Lecefel C, Eloy P, Chauvin B, Wyplosz B, Amilien V, Massias L, Taburet AM, Francois H, Furlan V.

J Clin Pharm Ther. 2015 Feb;40(1):119-20. doi: 10.1111/jcpt.12234. Epub 2014 Nov 24.

PMID:
25417855
16.

No booster dose for yellow fever vaccination: what are the consequences for the activity of vaccination in travel clinics?

Wyplosz B, Leroy JP, Derradji O, Consigny PH.

J Travel Med. 2015 Mar-Apr;22(2):140-1. doi: 10.1111/jtm.12173. Epub 2014 Nov 11.

17.

Bulky mediastinal aspergillosis mimicking cancer in an immunocompetent patient.

Stern JB, Wyplosz B, Validire P, Angoulvant A, Fregeville A, Caliandro R, Gossot D.

Ann Thorac Surg. 2014 Oct;98(4):1472-5. doi: 10.1016/j.athoracsur.2013.11.055.

PMID:
25282220
18.

Late-onset noninfectious interstitial lung disease after allogeneic hematopoietic stem cell transplantation.

Schlemmer F, Chevret S, Lorillon G, De Bazelaire C, Peffault de Latour R, Meignin V, Michallet M, Hermet E, Wyplosz B, Houdouin V, Marchand-Adam S, Socié G, Tazi A, Bergeron A.

Respir Med. 2014 Oct;108(10):1525-33. doi: 10.1016/j.rmed.2014.09.006. Epub 2014 Sep 16.

19.

Factors influencing posaconazole plasmatic concentrations in patients presenting with acute myeloid leukemia.

Desplanques PY, Burlacu R, Poinsignon V, Boussion H, Borget I, Wyplosz B, de Botton S, Billaud E, Chachaty E, Gachot B, Netzer F, Micol JB.

Med Mal Infect. 2014 Apr;44(4):174-9. doi: 10.1016/j.medmal.2014.02.005. Epub 2014 Mar 19.

PMID:
24656841
20.

Fatal measles pneumonitis during Hodgkin's lymphoma.

Wyplosz B, Lafarge M, Escaut L, Stern JB.

BMJ Case Rep. 2013 Oct 8;2013. pii: bcr2013200252. doi: 10.1136/bcr-2013-200252.

21.

Persistence of yellow fever vaccine-induced antibodies after solid organ transplantation.

Wyplosz B, Burdet C, François H, Durrbach A, Duclos-Vallée JC, Mamzer-Bruneel MF, Poujol P, Launay O, Samuel D, Vittecoq D, Consigny PH; GEVACCIM.

Am J Transplant. 2013 Sep;13(9):2458-61. doi: 10.1111/ajt.12338. Epub 2013 Jul 8.

22.

Safety and immunogenicity of yellow fever 17D vaccine in adults receiving systemic corticosteroid therapy: an observational cohort study.

Kernéis S, Launay O, Ancelle T, Iordache L, Naneix-Laroche V, Méchaï F, Fehr T, Leroy JP, Issartel B, Dunand J, van der Vliet D, Wyplosz B, Consigny PH, Hanslik T.

Arthritis Care Res (Hoboken). 2013 Sep;65(9):1522-8. doi: 10.1002/acr.22021.

23.

Management of rifamycins-everolimus drug-drug interactions in a liver-transplant patient with pulmonary tuberculosis.

Lefeuvre S, Rebaudet S, Billaud EM, Wyplosz B.

Transpl Int. 2012 Nov;25(11):e120-3. doi: 10.1111/j.1432-2277.2012.01561.x. Epub 2012 Sep 21. No abstract available.

24.

Design of a specific colonic mucus marker using a human commensal bacterium cell surface domain.

Coïc YM, Baleux F, Poyraz Ö, Thibeaux R, Labruyere E, Chretien F, Sobhani I, Lazure T, Wyplosz B, Schneider G, Mulard L, Sansonetti PJ, Marteyn BS.

J Biol Chem. 2012 May 4;287(19):15916-22. doi: 10.1074/jbc.M111.310003. Epub 2012 Mar 16.

25.

Generic drug prescriptions following hospital discharge: a prospective study in France.

Chu C, Rudant E, Bonvalet M, Agostini H, Cavalié P, Bonhomme-Faivre L, Frenkiel J, Taillandier J, Boissonnas A, Vittecoq D, Wyplosz B.

Eur J Intern Med. 2011 Oct;22(5):e45-9. doi: 10.1016/j.ejim.2011.01.016. Epub 2011 Mar 15.

PMID:
21925042
26.

Agreement between erythrocyte sedimentation rate and C-reactive protein in hospital practice.

Colombet I, Pouchot J, Kronz V, Hanras X, Capron L, Durieux P, Wyplosz B.

Am J Med. 2010 Sep;123(9):863.e7-13. doi: 10.1016/j.amjmed.2010.04.021.

PMID:
20800157
27.

Probable intrafamily transmission of a highly virulent CTX-M-3-producing Escherichia coli belonging to the emerging phylogenetic subgroup D2 O102-ST405 clone.

Mihaila L, Wyplosz B, Clermont O, Garry L, Hipeaux MC, Vittecoq D, Dussaix E, Denamur E, Branger C.

J Antimicrob Chemother. 2010 Jul;65(7):1537-9. doi: 10.1093/jac/dkq155. Epub 2010 May 13. No abstract available.

PMID:
20466852
28.

Sarcoidosis: an unusual cause of acute pericarditis.

Wyplosz B, Marijon E, Dougados J, Pouchot J.

Acta Cardiol. 2010 Feb;65(1):83-4.

PMID:
20306895
29.

Cerebrovascular diseases in HIV-infected patients.

Monsuez JJ, Goujon C, Wyplosz B, Couzigou C, Escaut L, Vittecoq D.

Curr HIV Res. 2009 Sep;7(5):475-80. Review.

PMID:
19534663
30.

HIV-associated vascular diseases: structural and functional changes, clinical implications.

Monsuez JJ, Charniot JC, Escaut L, Teicher E, Wyplosz B, Couzigou C, Vignat N, Vittecoq D.

Int J Cardiol. 2009 Apr 17;133(3):293-306. doi: 10.1016/j.ijcard.2008.11.113. Epub 2009 Jan 7. Review.

PMID:
19131130
31.

[Vaccinations for the traveling adult solid organ transplant recipient (excluding hematopoietic stem cell transplant recipients)].

Wyplosz B, Van der Vliet D, Consigny PH, Calmus Y, Mamzer-Bruneel MF, Guillemain R, Malvy D, Samuel D, Vittecoq D, Launay O; pour le groupe d'étude de la vaccination des immunodéprimés (GEVACCIM).

Med Mal Infect. 2009 Apr;39(4):225-33. doi: 10.1016/j.medmal.2008.11.006. Epub 2008 Dec 25. Review. French.

PMID:
19111416
32.

Thalidomide-induced pneumonitis.

Wyplosz B, Lerolle U, Israël-Biet D, Dougados J, Lillo-Le Louët A, Ghez D, Pouchot J.

Eur J Intern Med. 2008 Nov;19(7):e57-8. doi: 10.1016/j.ejim.2008.02.004. Epub 2008 Apr 18. No abstract available.

PMID:
19013366
33.

Initial human herpesvirus-8 rash and multicentric Castleman disease.

Wyplosz B, Carlotti A, Escaut L, Vignier N, Guettier C, Agbalika F, Vittecoq D, Dupin N.

Clin Infect Dis. 2008 Sep 1;47(5):684-8. doi: 10.1086/590942.

PMID:
18652555
34.

UV-light induced radiation recall dermatitis after a chemoradiotherapy organ preservation protocol.

Le Scodan R, Wyplosz B, Couchon S, Housset M, Laccourreye O.

Eur Arch Otorhinolaryngol. 2007 Sep;264(9):1099-102. Epub 2007 Apr 6.

PMID:
17415577
35.

Recurrent iodide mumps after repeated administration of contrast media.

Wyplosz B, Scotté F, Lillo-Le Louët A, Chevrot A.

Ann Intern Med. 2006 Jul 18;145(2):155-6. No abstract available.

PMID:
16847303
36.

Correlation between Chlamydia pneumoniae detection from coronary angioplasty balloons and atherosclerosis severity.

Wyplosz B, Montalescot G, Subtil A, Dujeancourt A, Tanguy ML, Choussat R, Capron L, Dautry-Varsat A.

J Am Coll Cardiol. 2006 Mar 21;47(6):1229-31. Epub 2006 Feb 23. No abstract available.

37.

Tolerance of diclofenac after hypersensitivity to celecoxib and to nabumetone.

Wyplosz B, Vautier S, Lillo-Le Louët A, Capron L.

Br J Clin Pharmacol. 2006 Apr;61(4):474. No abstract available.

38.

Imported tickborne relapsing fever, France.

Wyplosz B, Mihaila-Amrouche L, Baixench MT, Bigel ML, Berardi-Grassias L, Fontaine C, Hornstein M, Izri A, Baranton G, Postic D.

Emerg Infect Dis. 2005 Nov;11(11):1801-3. No abstract available.

39.

[Recurrent enterococcal bacteremia associated with a transjugular intrahepatic protosystemic shunt].

Passeron A, Mihaïla-Amrouche L, Perreira Rocha E, Wyplosz B, Capron L.

Gastroenterol Clin Biol. 2004 Dec;28(12):1284-6. French.

40.

Analysis of Chlamydia caviae entry sites and involvement of Cdc42 and Rac activity.

Subtil A, Wyplosz B, Balañá ME, Dautry-Varsat A.

J Cell Sci. 2004 Aug 1;117(Pt 17):3923-33. Epub 2004 Jul 20.

41.

Chlamydia--host cell interactions: recent advances on bacterial entry and intracellular development.

Dautry-Varsat A, Balañá ME, Wyplosz B.

Traffic. 2004 Aug;5(8):561-70. Review.

42.

[Infectious features of atherosclerosis].

Wyplosz B, Capron L.

Med Sci (Paris). 2004 Feb;20(2):169-74. Review. French.

43.

[Infections and atherosclerosis].

Wyplosz B.

Journ Annu Diabetol Hotel Dieu. 2000:113-23. Review. French. No abstract available.

PMID:
10932874
44.

Salvage therapy and long-term remission with danazol and cyclosporine in refractory Evan's syndrome.

Chemlal K, Wyplosz B, Grange MJ, Lassoued K, Clauvel JP.

Am J Hematol. 1999 Nov;62(3):200. No abstract available.

45.

[The infection theory in atherosclerosis].

Capron L, Wyplosz B.

Arch Mal Coeur Vaiss. 1998 Oct;91 Spec No 5:21-6. Review. French.

PMID:
9833076
46.

Case report: MRI and CT in a case of pituitary abscess.

Guigui J, Boukobza M, Tamer I, Guichard JP, Wyplosz B, Reizine D, Merland JJ.

Clin Radiol. 1998 Oct;53(10):777-9. No abstract available.

PMID:
9817100
47.

[The bacteriology of tuberculosis and non-tuberculosis mycobacterial infections].

Wyplosz B, Truffot-Pernot C, Robert J, Jarlier V, Grosset J.

Rev Mal Respir. 1997 Dec;14 Suppl 5:S33-48. Review. French.

PMID:
9496590
48.

[Thrombotic microangiopathy after chemo-embolization with cisplatin].

Blanche P, Wyplosz B, Herry I, Sicard D.

Ann Med Interne (Paris). 1995;146(6):452. French. No abstract available.

PMID:
8597351
49.

Pure red cell aplasia, peripheral thrombocytopenic purpura, and parvovirus B19 infection in a women seropositive for human immunodeficiency virus.

Blanche P, Wyplosz B, Herry I, Salmon D, Sicard D.

Clin Infect Dis. 1994 Jul;19(1):215. No abstract available.

PMID:
7948543
50.

Anorexia nervosa and gelatinous transformation of bone marrow.

Sicard D, Casadevall N, Wyplosz B, Picart F, Blanene P.

Nouv Rev Fr Hematol. 1994;36 Suppl 1:S85-6.

PMID:
8177724

Supplemental Content

Loading ...
Support Center